DK172094B1 - 1,4-Dihydropyridin-forbindelser, farmaceutiske præparater indeholdende disse og deres anvendelse til deres fremstilling af lægemidler samt beskyttede derivater deraf til anvendelse som udgangsmateriale ved deres fremstilling - Google Patents
1,4-Dihydropyridin-forbindelser, farmaceutiske præparater indeholdende disse og deres anvendelse til deres fremstilling af lægemidler samt beskyttede derivater deraf til anvendelse som udgangsmateriale ved deres fremstilling Download PDFInfo
- Publication number
- DK172094B1 DK172094B1 DK264388A DK234388A DK172094B1 DK 172094 B1 DK172094 B1 DK 172094B1 DK 264388 A DK264388 A DK 264388A DK 234388 A DK234388 A DK 234388A DK 172094 B1 DK172094 B1 DK 172094B1
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- cycloocta
- amylose
- starch
- dioxa
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title description 9
- 239000003814 drug Substances 0.000 title description 2
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical class C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000007858 starting material Substances 0.000 title 1
- 125000004429 atom Chemical group 0.000 claims description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- -1 hydroxy, methoxy, ethoxy Chemical group 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 abstract description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 208000009304 Acute Kidney Injury Diseases 0.000 abstract 1
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 208000033626 Renal failure acute Diseases 0.000 abstract 1
- 206010062237 Renal impairment Diseases 0.000 abstract 1
- 201000011040 acute kidney failure Diseases 0.000 abstract 1
- 208000012998 acute renal failure Diseases 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 26
- 229920002472 Starch Polymers 0.000 description 20
- 235000019698 starch Nutrition 0.000 description 20
- 239000008107 starch Substances 0.000 description 20
- 238000000034 method Methods 0.000 description 10
- 239000008139 complexing agent Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 241000178960 Paenibacillus macerans Species 0.000 description 4
- QARVLSVVCXYDNA-UHFFFAOYSA-N bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- QCSDLMPAQMQZOE-FMGPEAFSSA-N (1e,9e)-cyclohexadeca-1,9-diene Chemical compound C1CCC\C=C\CCCCCC\C=C\CC1 QCSDLMPAQMQZOE-FMGPEAFSSA-N 0.000 description 3
- MKEIDVFLAWJKMY-UHFFFAOYSA-N 1,7-dioxacycloheptadecan-8-one Chemical compound O=C1CCCCCCCCCOCCCCCO1 MKEIDVFLAWJKMY-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 108010025880 Cyclomaltodextrin glucanotransferase Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZGEHHVDYDNXYMW-UHFFFAOYSA-N cyclohexadec-8-en-1-one Chemical compound O=C1CCCCCCCC=CCCCCCC1 ZGEHHVDYDNXYMW-UHFFFAOYSA-N 0.000 description 3
- VHUGWUBIUBBUAF-UHFFFAOYSA-N cyclotridecanone Chemical compound O=C1CCCCCCCCCCCC1 VHUGWUBIUBBUAF-UHFFFAOYSA-N 0.000 description 3
- 229960004592 isopropanol Drugs 0.000 description 3
- 229920001592 potato starch Polymers 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000001807 (9E)-cycloheptadec-9-en-1-one Substances 0.000 description 2
- GJJSUPSPZIZYPM-UHFFFAOYSA-N 1,4-dioxacyclohexadecane-5,16-dione Chemical compound O=C1CCCCCCCCCCC(=O)OCCO1 GJJSUPSPZIZYPM-UHFFFAOYSA-N 0.000 description 2
- FXKHTSOJWNCNRI-UHFFFAOYSA-N 15-oxabicyclo[12.1.0]pentadec-7-ene Chemical compound C1CCCCC=CCCCCCC2OC21 FXKHTSOJWNCNRI-UHFFFAOYSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- SXVPOSFURRDKBO-UHFFFAOYSA-N Cyclododecanone Chemical compound O=C1CCCCCCCCCCC1 SXVPOSFURRDKBO-UHFFFAOYSA-N 0.000 description 2
- WHGYBXFWUBPSRW-UHFFFAOYSA-N Cycloheptaamylose Natural products O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO WHGYBXFWUBPSRW-UHFFFAOYSA-N 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- 229920002245 Dextrose equivalent Polymers 0.000 description 2
- XRHCAGNSDHCHFJ-UHFFFAOYSA-N Ethylene brassylate Chemical compound O=C1CCCCCCCCCCCC(=O)OCCO1 XRHCAGNSDHCHFJ-UHFFFAOYSA-N 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- 229930092411 Swietenocoumarin D Natural products 0.000 description 2
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 2
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- ZKVZSBSZTMPBQR-UHFFFAOYSA-N cycloheptadec-9-en-1-one Chemical compound O=C1CCCCCCCC=CCCCCCCC1 ZKVZSBSZTMPBQR-UHFFFAOYSA-N 0.000 description 2
- CDJMUDSSRKZTDJ-UHFFFAOYSA-N cyclotetradec-7-en-1-one Chemical compound O=C1CCCCCCC=CCCCCC1 CDJMUDSSRKZTDJ-UHFFFAOYSA-N 0.000 description 2
- 238000010908 decantation Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- QJDXLECULVHLTA-OWOJBTEDSA-N (8e)-17-oxabicyclo[14.1.0]heptadec-8-ene Chemical compound C1CCCCC\C=C\CCCCCCC2OC21 QJDXLECULVHLTA-OWOJBTEDSA-N 0.000 description 1
- ZGEHHVDYDNXYMW-UPHRSURJSA-N (8z)-cyclohexadec-8-en-1-one Chemical compound O=C1CCCCCCC\C=C/CCCCCC1 ZGEHHVDYDNXYMW-UPHRSURJSA-N 0.000 description 1
- KUZFTOAYXWRQAA-UPHRSURJSA-N (8z)-cyclopentadec-8-en-1-one Chemical compound O=C1CCCCCC\C=C/CCCCCC1 KUZFTOAYXWRQAA-UPHRSURJSA-N 0.000 description 1
- XFQHIELVPOKJIM-UHFFFAOYSA-N 1,4-dioxacyclotetradecane-5,14-dione Chemical compound O=C1CCCCCCCCC(=O)OCCO1 XFQHIELVPOKJIM-UHFFFAOYSA-N 0.000 description 1
- RFQCCPKKTMJJET-UHFFFAOYSA-N 1,4-dioxaspiro[4.15]icosane Chemical compound O1CCOC11CCCCCCCCCCCCCCC1 RFQCCPKKTMJJET-UHFFFAOYSA-N 0.000 description 1
- KTOHRMAEFBZKTE-UHFFFAOYSA-N 1,5,9,13-tetramethylcyclohexadeca-1,5,9,13-tetraene Chemical compound CC1=CCCC(C)=CCCC(C)=CCCC(C)=CCC1 KTOHRMAEFBZKTE-UHFFFAOYSA-N 0.000 description 1
- MRMOPGVGWFNHIN-UHFFFAOYSA-N 1,6-dioxacycloheptadecan-7-one Chemical compound O=C1CCCCCCCCCCOCCCCO1 MRMOPGVGWFNHIN-UHFFFAOYSA-N 0.000 description 1
- ITWWEYPYLJIKTB-UHFFFAOYSA-N 1-azacyclotetradec-9-en-2-one Chemical compound O=C1CCCCCCC=CCCCCN1 ITWWEYPYLJIKTB-UHFFFAOYSA-N 0.000 description 1
- ALVVVGFCZNOOFD-UHFFFAOYSA-N 13-hydroxyimino-oxacyclohexadecan-2-one Chemical compound ON=C1CCCCCCCCCCC(=O)OCCC1 ALVVVGFCZNOOFD-UHFFFAOYSA-N 0.000 description 1
- IUDIJIVSWGWJNV-UHFFFAOYSA-N 13-tridecanolide Chemical compound O=C1CCCCCCCCCCCCO1 IUDIJIVSWGWJNV-UHFFFAOYSA-N 0.000 description 1
- LOKPJYNMYCVCRM-UHFFFAOYSA-N 16-Hexadecanolide Chemical compound O=C1CCCCCCCCCCCCCCCO1 LOKPJYNMYCVCRM-UHFFFAOYSA-N 0.000 description 1
- NCGQTXHIOQZATM-UHFFFAOYSA-N 16-oxabicyclo[13.1.0]hexadec-8-ene Chemical compound C1CCCCC=CCCCCCCC2OC21 NCGQTXHIOQZATM-UHFFFAOYSA-N 0.000 description 1
- ZCAWTINMLHVGOY-UHFFFAOYSA-N 17-oxabicyclo[14.1.0]heptadeca-4,8,12-triene Chemical compound C1CC=CCCC=CCCC=CCCC2OC21 ZCAWTINMLHVGOY-UHFFFAOYSA-N 0.000 description 1
- RCOKMWAKYZDWAA-UHFFFAOYSA-N 2-methyl-1,4-dioxacyclohexadecane-5,16-dione Chemical compound CC1COC(=O)CCCCCCCCCCC(=O)O1 RCOKMWAKYZDWAA-UHFFFAOYSA-N 0.000 description 1
- DWDUMNPMUZVGRS-UHFFFAOYSA-N 8,9-dimethoxycyclohexadecene Chemical compound COC1CCCCCCCC=CCCCCCC1OC DWDUMNPMUZVGRS-UHFFFAOYSA-N 0.000 description 1
- OVMFRYKLEUFMRG-UHFFFAOYSA-N 9-methoxycyclohexadecene Chemical compound COC1CCCCCCCC=CCCCCCC1 OVMFRYKLEUFMRG-UHFFFAOYSA-N 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 241000193407 Bacillus ohbensis Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 241000191938 Micrococcus luteus Species 0.000 description 1
- ALHUZKCOMYUFRB-OAHLLOKOSA-N Muscone Chemical compound C[C@@H]1CCCCCCCCCCCCC(=O)C1 ALHUZKCOMYUFRB-OAHLLOKOSA-N 0.000 description 1
- RRRJPUARDNCUMY-UHFFFAOYSA-N N-cyclohexadec-8-en-1-ylidenehydroxylamine Chemical compound ON=C1CCCCCCCC=CCCCCCC1 RRRJPUARDNCUMY-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- FXRYNTPSWKKHOY-UHFFFAOYSA-N cyclohexadec-8-en-1-yl acetate Chemical compound CC(=O)OC1CCCCCCCC=CCCCCCC1 FXRYNTPSWKKHOY-UHFFFAOYSA-N 0.000 description 1
- SFWOYLWPQYGZHK-UHFFFAOYSA-N cyclohexadeca-4,8,12-trien-1-ol Chemical compound OC1CCCC=CCCC=CCCC=CCC1 SFWOYLWPQYGZHK-UHFFFAOYSA-N 0.000 description 1
- IBHQQFOERGXDMC-UHFFFAOYSA-N cyclohexadecane-1,8-diol Chemical compound OC1CCCCCCCCC(O)CCCCCC1 IBHQQFOERGXDMC-UHFFFAOYSA-N 0.000 description 1
- ATENIBAYQJJHST-UHFFFAOYSA-N cyclohexadecane-1,9-diol Chemical compound OC1CCCCCCCC(O)CCCCCCC1 ATENIBAYQJJHST-UHFFFAOYSA-N 0.000 description 1
- VSQURHGSZWBWFZ-UHFFFAOYSA-N cyclohexadecane-1,9-dione Chemical compound O=C1CCCCCCCC(=O)CCCCCCC1 VSQURHGSZWBWFZ-UHFFFAOYSA-N 0.000 description 1
- AQLCQUACLXRPKV-UHFFFAOYSA-N cyclopentadeca-1,8-diene Chemical compound C1CCCC=CCCCCCC=CCC1 AQLCQUACLXRPKV-UHFFFAOYSA-N 0.000 description 1
- VPBPFAIWNCCMAY-UHFFFAOYSA-N cyclotetracosa-1,9,17-triene Chemical compound C1CCCC=CCCCCCCC=CCCCCCCC=CCC1 VPBPFAIWNCCMAY-UHFFFAOYSA-N 0.000 description 1
- HJOXXAJXPKIPQX-UHFFFAOYSA-N cyclotetradec-7-en-1-ol Chemical compound OC1CCCCCCC=CCCCCC1 HJOXXAJXPKIPQX-UHFFFAOYSA-N 0.000 description 1
- WCMISCDQOHKOAN-UHFFFAOYSA-N cyclotetradeca-1,8-diene Chemical compound C1CCC=CCCCCCC=CCC1 WCMISCDQOHKOAN-UHFFFAOYSA-N 0.000 description 1
- FUGDHQXYVPQGLJ-UHFFFAOYSA-N cyclotetradecanone Chemical compound O=C1CCCCCCCCCCCCC1 FUGDHQXYVPQGLJ-UHFFFAOYSA-N 0.000 description 1
- DGJAEYIZIUUWSJ-UHFFFAOYSA-N dec-8-enal Chemical compound CC=CCCCCCCC=O DGJAEYIZIUUWSJ-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- NQMRYBIKMRVZLB-UHFFFAOYSA-N methylamine hydrochloride Chemical compound [Cl-].[NH3+]C NQMRYBIKMRVZLB-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- SSZUPSDXTFXCLS-UHFFFAOYSA-N n-cyclotridecylidenehydroxylamine Chemical compound ON=C1CCCCCCCCCCCC1 SSZUPSDXTFXCLS-UHFFFAOYSA-N 0.000 description 1
- 229940038384 octadecane Drugs 0.000 description 1
- LFSYLMRHJKGLDV-UHFFFAOYSA-N oxacyclopentadecan-2-one Chemical compound O=C1CCCCCCCCCCCCCO1 LFSYLMRHJKGLDV-UHFFFAOYSA-N 0.000 description 1
- 150000002966 pentacyclic triterpenoids Chemical class 0.000 description 1
- 239000004476 plant protection product Substances 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920001470 polyketone Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 150000003521 tetracyclic triterpenoids Chemical class 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Dental Preparations (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB878710493A GB8710493D0 (en) | 1987-05-02 | 1987-05-02 | Dihydropyridines |
| GB8710493 | 1987-05-02 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK234388D0 DK234388D0 (da) | 1988-04-28 |
| DK234388A DK234388A (da) | 1989-01-19 |
| DK172094B1 true DK172094B1 (da) | 1997-10-20 |
Family
ID=10616773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK264388A DK172094B1 (da) | 1987-05-02 | 1988-04-28 | 1,4-Dihydropyridin-forbindelser, farmaceutiske præparater indeholdende disse og deres anvendelse til deres fremstilling af lægemidler samt beskyttede derivater deraf til anvendelse som udgangsmateriale ved deres fremstilling |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4806557A (enExample) |
| EP (1) | EP0290211B1 (enExample) |
| JP (1) | JPS63297365A (enExample) |
| AT (1) | ATE66915T1 (enExample) |
| CA (1) | CA1326672C (enExample) |
| DE (1) | DE3864573D1 (enExample) |
| DK (1) | DK172094B1 (enExample) |
| ES (1) | ES2031595T3 (enExample) |
| FI (1) | FI90415C (enExample) |
| GB (1) | GB8710493D0 (enExample) |
| GR (1) | GR3002767T3 (enExample) |
| IE (1) | IE60055B1 (enExample) |
| PT (1) | PT87361B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5270323A (en) * | 1990-05-31 | 1993-12-14 | Pfizer Inc. | Method of treating impotence |
| US6057344A (en) | 1991-11-26 | 2000-05-02 | Sepracor, Inc. | Methods for treating hypertension, and angina using optically pure (-) amlodipine |
| DK1196414T3 (da) * | 1999-06-25 | 2003-11-24 | Vertex Pharma | Prolægemiddel af carbamathæmmer for IMPDH |
| US6521647B2 (en) | 2000-04-04 | 2003-02-18 | Pfizer Inc. | Treatment of renal disorders |
| GB0008332D0 (en) * | 2000-04-04 | 2000-05-24 | Pfizer Ltd | Treament |
| BR0116553A (pt) | 2000-12-29 | 2004-02-03 | Pfizer Ltd | Composto, composição farmacêutica para tratamento de angina ou hipertensão, processo, processo para tratamento ou prevenção de angina ou hipertensão, composição de ingredientes farmaceuticamente ativos, composição farmacêutica para tratamento ou prevenção de angina ou hipertensão e processo para tratar ou prevenir angina ou hipertensão |
| WO2002053541A1 (en) | 2000-12-29 | 2002-07-11 | Pfizer Limited | Amide derivative of amlodipine |
| AT5874U1 (de) | 2000-12-29 | 2003-01-27 | Bioorg Bv | Pharmazeutische zubereitungen enthaltend amlodipinmaleat |
| CA2433181C (en) | 2000-12-29 | 2005-11-22 | Pfizer Limited | Amlodipine hemifumarate |
| RS53403A (sr) | 2000-12-29 | 2006-10-27 | Pfizer Limited | Postupak za dobijanje amlodipin maleata |
| CA2433284A1 (en) | 2000-12-29 | 2002-07-11 | Pfizer Limited | Reference standards and processes for determining the purity or stability of amlodipine maleate |
| BR0116552A (pt) | 2000-12-29 | 2004-02-03 | Pfizer Ltd | Hemi-maleato de amlodipina, processo, método para o tratamento ou prevenção de angina ou hipertensão, composição farmacêutica, para uso no tratamento e/ou de angina ou da hipertensão |
| US6653481B2 (en) | 2000-12-29 | 2003-11-25 | Synthon Bv | Process for making amlodipine |
| US7335380B2 (en) | 2000-12-29 | 2008-02-26 | Synthon Ip Inc. | Amlodipine free base |
| MXPA03005882A (es) | 2000-12-29 | 2005-04-19 | Pfizer Ltd | Derivado amida de amlodipina. |
| US6699892B2 (en) | 2002-06-04 | 2004-03-02 | Yung Shin Pharmaceutical Industrial Co., Ltd. | Pharmaceutically acceptable salt of amlodipine and method of preparing the same |
| KR100496436B1 (ko) * | 2002-07-30 | 2005-06-20 | 씨제이 주식회사 | 암로디핀의 유기산염 |
| KR100462304B1 (ko) * | 2002-07-30 | 2004-12-17 | 씨제이 주식회사 | 암로디핀의 유기산염 |
| KR100538641B1 (ko) * | 2002-07-30 | 2005-12-22 | 씨제이 주식회사 | 암로디핀의 유기산염 |
| KR20040011751A (ko) * | 2002-07-30 | 2004-02-11 | 씨제이 주식회사 | 암로디핀의 유기산염 |
| KR100467669B1 (ko) * | 2002-08-21 | 2005-01-24 | 씨제이 주식회사 | 암로디핀의 유기산염 |
| KR20130061148A (ko) | 2010-05-03 | 2013-06-10 | 티에스에이치 바이오팜 코포레이션 리미티드 | 고혈압 치료용 약학 조성물 및 방법 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1552911A (en) * | 1975-07-02 | 1979-09-19 | Fujisawa Pharmaceutical Co | 1,4 dihydropyridine derivatives and the preparation thereof |
| US4447613A (en) * | 1979-08-24 | 1984-05-08 | Zoecon Corporation | Pyridyl esters and thiolesters of aminoalkanoic acids |
| CS228917B2 (en) * | 1981-03-14 | 1984-05-14 | Pfizer | Method of preparing substituted derivatives of 1,4-dihydropyridine |
| DK161312C (da) * | 1982-03-11 | 1991-12-09 | Pfizer | Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden |
| GB8306666D0 (en) * | 1983-03-10 | 1983-04-13 | Pfizer Ltd | Therapeutic agents |
| US4568677A (en) * | 1983-07-23 | 1986-02-04 | Pfizer Inc. | 2-(4-Pyrimidone alkoxyalkyl) dihydropyridine anti-ischaemic and antihypertensive agents |
-
1987
- 1987-05-02 GB GB878710493A patent/GB8710493D0/en active Pending
-
1988
- 1988-04-28 US US07/187,116 patent/US4806557A/en not_active Expired - Lifetime
- 1988-04-28 FI FI882001A patent/FI90415C/fi not_active IP Right Cessation
- 1988-04-28 DK DK264388A patent/DK172094B1/da not_active IP Right Cessation
- 1988-04-29 CA CA000565483A patent/CA1326672C/en not_active Expired - Fee Related
- 1988-04-29 DE DE8888303940T patent/DE3864573D1/de not_active Expired - Lifetime
- 1988-04-29 IE IE128388A patent/IE60055B1/en not_active IP Right Cessation
- 1988-04-29 AT AT88303940T patent/ATE66915T1/de not_active IP Right Cessation
- 1988-04-29 EP EP88303940A patent/EP0290211B1/en not_active Expired - Lifetime
- 1988-04-29 ES ES198888303940T patent/ES2031595T3/es not_active Expired - Lifetime
- 1988-04-29 PT PT87361A patent/PT87361B/pt not_active IP Right Cessation
- 1988-04-30 JP JP63108909A patent/JPS63297365A/ja active Granted
-
1991
- 1991-09-20 GR GR91401379T patent/GR3002767T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0290211B1 (en) | 1991-09-04 |
| PT87361A (pt) | 1989-05-31 |
| DK234388D0 (da) | 1988-04-28 |
| EP0290211A1 (en) | 1988-11-09 |
| JPH0581588B2 (enExample) | 1993-11-15 |
| FI882001A0 (fi) | 1988-04-28 |
| ES2031595T3 (es) | 1992-12-16 |
| ATE66915T1 (de) | 1991-09-15 |
| PT87361B (pt) | 1992-08-31 |
| DE3864573D1 (en) | 1991-10-10 |
| IE60055B1 (en) | 1994-05-18 |
| GB8710493D0 (en) | 1987-06-03 |
| IE881283L (en) | 1988-11-02 |
| FI90415B (fi) | 1993-10-29 |
| FI882001A7 (fi) | 1988-11-03 |
| FI90415C (fi) | 1994-02-10 |
| CA1326672C (en) | 1994-02-01 |
| US4806557A (en) | 1989-02-21 |
| JPS63297365A (ja) | 1988-12-05 |
| DK234388A (da) | 1989-01-19 |
| GR3002767T3 (en) | 1993-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mocek et al. | Biosynthesis of the modified peptide antibiotic thiostrepton in Streptomyces azureus and Streptomyces laurentii | |
| JP4810043B2 (ja) | 細胞分裂阻害剤及びその製造方法 | |
| Sundar Raj et al. | Transduction in Mycobacterium smegmatis | |
| US4822874A (en) | Process for preparing cyclooctaamylose | |
| CH619267A5 (enExample) | ||
| JPWO2001053290A1 (ja) | 細胞分裂阻害剤及びその製造方法 | |
| FR2771105A1 (fr) | Utilisation du fusarium monoliforme pour la preparation des derives 7alpha-hydroxyles de la dehydroepiandrosterone et de la pregnenolone | |
| Koizumi et al. | Isolation and characterization of novel heterogeneous branched cyclomalto-oligosaccharides (cyclodextrins) produced by transgalactosylation with α-galactosidase from coffee bean | |
| Hochstein et al. | 2-Acetyl-2-decarboxamidoöxytetracycline | |
| Bryant Jr et al. | Menaquinone biosynthesis: conversion of o-succinylbenzoic acid to 1, 4-dihydroxy-2-naphthoic acid and menaquinones by Escherichia coli extracts | |
| DK147914B (da) | Lithiumpseudomonat og fremgangsmaade til fremstilling deraf | |
| Klepp et al. | Mechanism of action of urocanase: Specific 13C‐labelling of the prosthetic NAD+ and revision of the structure of its adduct with imidazolylpropionate | |
| Ehrlich et al. | Simple method for isolation of 4-deoxynivalenol from rice inoculated with Fusarium graminearum | |
| US3896002A (en) | Production of brefeldin-A | |
| Tischler et al. | Rifamycin derivatives as inhibitors of a ribonucleic acid instructed deoxyribonucleic acid polymerase function. Effect of lipophilicity | |
| De Ley et al. | Comparative D-gluconate metabolism and DNA base composition in Achromobacter and Alcaligenes | |
| JPH0643436B2 (ja) | 新規物質トレハロスタチンおよびその製造方法 | |
| CN102718818B (zh) | 含氮曲克芦丁衍生物及其制备方法和用途 | |
| CN105063137A (zh) | 一种基于施氏假单胞菌细胞催化的秦皮甲素羟基保护反应方法 | |
| RU2807924C1 (ru) | N-ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ 6α-ПИПЕРАЗИНОМЕТИЛАНДРОСТ-4-ЕН-3,17-ДИОНА, ОБЛАДАЮЩИЕ АНТИМИКРОБНОЙ АКТИВНОСТЬЮ, И СПОСОБ ИХ ПОЛУЧЕНИЯ | |
| CN121824569A (zh) | 一种用于促进毛囊再生的化合物及其应用 | |
| DK143606B (da) | Fremgangsmaade til fremstilling af dihydromocimycin eller salte heraf | |
| JP3759207B2 (ja) | 抗菌剤及び医薬組成物 | |
| JPH06135987A (ja) | フラノン配糖体及びその製造法 | |
| Hamayasu et al. | Synthesis of N-acetylglucosaminyl-maltosyl-cyclodextrin by lysozyme |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B1 | Patent granted (law 1993) | ||
| PUP | Patent expired |